GleanMark

VEDA TRIALS Trademark

VEDA TRIALS is a USPTO trademark filed by VEDA LIFE SCIENCES, INC.. Status: Pending.

Trademark Facts

MarkVEDA TRIALS
Serial Number98091041
StatusPending
Filing Date2023-07-18
Mark TypeWord
Nice Classes042 (Software & IT)
OwnerVEDA LIFE SCIENCES, INC.
Attorney of RecordELIZABETH OLINER
Prosecution Events38
Latest EventEISU on 2026-02-18

Goods & Services

TRIALS; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Platform as a service (PAAS) featuring computer software platforms for use in running, managing and analyzing clinical trials, namely, enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients that need them most; Platform as a service (PAAS) featuring computer software platforms for use in managing and participating in clinical research and view data analytics, enabling site data capture, conducting virtual visits through telehealth video calls, selecting configurable data collection methods with configurable options and configuring a participant-facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring non-downloadable software for use in clinical research analytics, data capture forms, telehealth, electronic clinical outcome assessments (eCOA), recruitment, and electronic consent; Providing a website featuring non- downloadable software for enabling users to manage and participate in clinical research, view data analytics, enable site data capture, and screen participants for eligibility; Providing information in the field of clinical research via a website; Providing medical and scientific research information in the field of clinical trials

Recent Prosecution Activity

DateDocumentType
2024-11-13LOP Memo to EATLADMR
2024-09-30Examiner's AmendmentEXAMA
2024-06-28Response to Office ActionROA
2024-06-07LOP Memo to EATLADMR
2024-05-24Non-Final ActionNFIN

Related